To further explore Ryk immunoreactivity within the striatum of HD patients, we performed double immunofluorescence for Ryk in combination with either calbindin or NOS immunoreactivities, labeling degenerating and relatively unaffected striatal neurons, respectively. This evidence concerns the gene CALB1 and Huntington disease.